Duoli Sun
YOU?
Author Swipe
View article: Data from Designing and Developing S100P Inhibitor 5-Methyl Cromolyn for Pancreatic Cancer Therapy
Data from Designing and Developing S100P Inhibitor 5-Methyl Cromolyn for Pancreatic Cancer Therapy Open
We have previously shown that the antiallergic drug cromolyn blocks S100P interaction with its receptor receptor for advanced glycation end product (RAGE) and improves gemcitabine effectiveness in pancreatic ductal adenocarcinoma (PDAC). H…
View article: Data from Designing and Developing S100P Inhibitor 5-Methyl Cromolyn for Pancreatic Cancer Therapy
Data from Designing and Developing S100P Inhibitor 5-Methyl Cromolyn for Pancreatic Cancer Therapy Open
We have previously shown that the antiallergic drug cromolyn blocks S100P interaction with its receptor receptor for advanced glycation end product (RAGE) and improves gemcitabine effectiveness in pancreatic ductal adenocarcinoma (PDAC). H…
View article: Supplementary Materials and Methods from Designing and Developing S100P Inhibitor 5-Methyl Cromolyn for Pancreatic Cancer Therapy
Supplementary Materials and Methods from Designing and Developing S100P Inhibitor 5-Methyl Cromolyn for Pancreatic Cancer Therapy Open
PDF file - 124 KB, Synthesis of Cromolyn Analogs:Lead compound C5OH synthesis is presented in material and method sections. Other analogs synthesis procedure is provided as supplementary material.
View article: Supplementary Materials and Methods from Designing and Developing S100P Inhibitor 5-Methyl Cromolyn for Pancreatic Cancer Therapy
Supplementary Materials and Methods from Designing and Developing S100P Inhibitor 5-Methyl Cromolyn for Pancreatic Cancer Therapy Open
PDF file - 124 KB, Synthesis of Cromolyn Analogs:Lead compound C5OH synthesis is presented in material and method sections. Other analogs synthesis procedure is provided as supplementary material.